Healthy Returns: Employers aren't expanding coverage of GLP-1 obesity drugs — many are finding ways around it

According to CNBC, employer coverage of GLP-1 weight loss drugs has plateaued at thirty-six percent, with many companies seeking workarounds to avoid broadening their coverage.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton